Latest UK News
A new study funded by the MRC and Wellcome, and published today in the journal Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, has found that the wakefulness-promoting drug modafinil improves memory functions in people recovering from depression.
Academic training for research-active clinicians needs to be acknowledged, recognised and integrated with clinical training and work, says funders’ new report on principles and obligations outlining best practice.
For the first time, researchers have shown that the number of parasites each mosquito carries influences the chance of successful malaria infection. The finding has implications for vaccine development and studies into how the disease spreads.
Congratulations to the MRC-associated people who have been recognised in the 2017 New Year’s Honours list.
The MRC requires that the results of the research it funds are published, ideally in peer-reviewed journals; also that all such articles, whether published in an open access or subscription-based journal, must be archived in Europe PubMed Central (Europe PMC) and made freely available as soon as possible.
Professor David Lomas has been appointed as the MRC’s new Deputy Chief Executive. He will take up a fixed term position on 1 January 2017 which will run to 31 March 2018.
Research councils join forces to harness the UK’s world-class research expertise to improve the health and prosperity of billions of people in low and middle income countries
The Director of the UK DRI has been named as Professor Bart De Strooper, from the University of Leuven, Belgium. Professor De Strooper will lead the national institute from UCL, to transform the UK’s research efforts to diagnose, treat, care for and prevent dementias.
Two new members have been appointed to the Council of the Medical Research Council (MRC) by the Minister for Universities and Science, Jo Johnson.
Experts from the MRC Centre for Medical Mycology at the University of Aberdeen have discovered how the fungus which causes thrush tries to hide from our body’s defences. Candida albicans can be deadly when it takes advantage of the weakened immune systems of cancer or transplant patients.